News >
02/11/2004 - 21:00

Delays hurt C3 share price

By Staff Reporters
02/11/2004 - 21:00
Share to

Bookmark

Save articles for future reference.
Subscribe to BN Log In

CLINICAL Cell Culture’s share price has taken a hammering this week after the company disclosed delays in the commercial introduction of its CellSpray and CellSpray XP products.

X

To read our articles you will need to either login or subscribe.